Effect of radiosynovectomy with holmium-166 ferric hydroxide macroaggregate on adult equine cartilage.

The research focuses on analyzing the impact of a specific treatment method, radiosynovectomy with holmium-166 ferric hydroxide macroaggregate (166Ho-FHMA), on adult horse joint cartilage, particularly looking at changes in arthritic conditions, cartilage structure, and relevant molecular components.

Research Method and Process

• The researchers’ approach is centered on observing changes in 6 adult horses post radiosynovectomy with 166Ho-FHMA, focusing on the articular cartilage.
• Techniques such as arthroscopy and microscopic analysis after death were used to evaluate potential arthritis changes and articular cartilage’s mechanical attributes.
• They also measured the glycosaminoglycan content—a crucial component of cartilage—using the safranin-O staining method, digital densitometry, uronic acid analyses, and dimethylene blue binding assay.
• To examine proteoglycan synthesis localization and structure (proteoglycans are key cartilage components), the researchers used techniques including 35S-sulfate labeling, autoradiography, and SDS-agarose gel electrophoresis.
• Finally, Northern hybridizations were performed to gauge the mRNA levels for aggrecan and pro-a1(II) collagen—both substantial elements in the cartilage matrix—in the cartilage samples.

Research Findings

• The study detected signs of degeneration in articular cartilage, both in control (untreated) and radiosynovectomized equine joints.
• Radiosynovectomy with 166Ho-FHMA did not further stimulate degenerative changes or considerably modify the matrix glycosaminoglycan content.
• A slight decrease in the size of proteoglycan monomers was noticed 2 months post radiosynovectomy.
• Cartilage tissue analysis showed a decrease in 35S incorporation after treatment, but no corresponding changes were noticed in aggrecan mRNA levels.
• A short-term downregulation of pro-a1(II) collagen mRNA was evident 5 days post radiosynovectomy.

Study Conclusions

• The findings affirm that 166Ho-FHMA treatment does not significantly affect the composition or morphology of adult articular cartilage, even those showing mild degeneration.
• However, minor degradation of proteoglycan monomers and a temporary downregulation of pro-a1(II) collagen mRNA were observed post treatment.